The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma

Journal of Clinical Neuroscience

Volumn 10, Issue 3, 2003, Pages 320-324

  Fukui, Shinji ^a   Otani, Naoki ^a   Nawashiro, Hiroshi ^a   Yano, Akiko ^a   Nomura, Namiko ^a   Tokumaru, Aya M ^a   Miyazawa, Takahito ^a   Ohnuki, Akira ^a   Tsuzuki, Nobusuke ^a   Katoh, Hiroshi ^a   Ishihara, Shoichiro ^a   Shima, Katsuji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Cystic component; Haemorrhage; Pituitary adenoma; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CYST; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BLEEDING; TUMOR VASCULARIZATION;

EID: 0037833473     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(03)00013-4     Document Type: Article

References (30)

1. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 1997; 18: 1155-1161.
2. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858.
3. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
4. Xiong S, Grijalva R, Zhang L et al. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-β1-activated p38 signaling pathway enhances endothelial cell migration. Cancer Res 2001; 61: 1727-1732.
5. Cheng SY, Nagane M, Huang HS, Cavenee WK. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA 1997; 94: 12081-12087.
6. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991; 47: 219-223.
7. Senger DR, Connolly DT, van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990; 50: 1774-1778.
8. Vaquero J, Zurita M, de Oya S, Coca S, Morales C, Salas C. Expression of vascular permeability factor in craniopharyngioma. J Neurosurg 1999; 91: 831-834.
9. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140: 947-959.
10. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108: 2369-2379.
11. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997; 57: 765-772.
12. Suarez S, Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 2001; 114: 1229-1235.
13. Berkman RA, Merrill MJ, Reinhold WC et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993; 91: 153-159.
14. Takano S, Yoshii Y, Kondo S et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996; 56: 2185-2190.
15. Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery 1982; 10: 437-444.
16. Kannuki S, Bando K, Shirakawa N et al. [MRI findings and endocrinological dysfunction in hemorrhagic pituitary adenoma. No Shinkei Geka 1993; 21: 1005-1012.
17. Cardoso ER, Peterson EW. Pituitary apoplexy: a review. Neurosurgery 1984; 14: 363-373.
18. Kurihara N, Takahashi S, Higano S et al. Hemorrhage in pituitary adenoma: correlation of MR imaging with operative findings. Eur Radiol 1998; 8: 971-976.
19. Yoshioka H, Kurisu K, Arita K. Tominaga A. A case of non-functioning pituitary adenoma accompanied by a large cyst. Acta Neurochir (Wien) 1998; 140: 293-294.
20. Nishikawa R, Cheng SY, Nagashima R, Huang HJ, Cavenee WK, Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol (Berl) 1998; 96: 453-462.
21. Gross PM, Blasberg RG, Fenstermacher JD, Patlak CS. The microcirculation of rat circumventricular organs and pituitary gland. Brain Res Bull 1987; 18: 73-85.
22. Mohanty S, Tandon PN, Banerji AK, Prakash B. Haemorrhage into pituitary adenomas. J Neurol Neurosurg Psychiatry 1977; 40: 987-991.
23. Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 1982; 18: 181-189.
24. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 1981; 55: 187-193.
25. Armstrong MR, Douek M, Schellinger D, Patronas NJ. Regression of pituitary macroadenoma after pituitary apoplexy: CT and MR studies. J Comput Assist Tomogr 1991; 15: 832-834.
26. Corkill G, Hanson FW, Sobel RA, Keller TM. Apoplexy in a prolactin microadenoma leading to remission of galactorrhea and amenorrhea. Surg Neurol 1981; 15: 114-115.
27. Schatz NJ, Job OM, Glaser JS. Spontaneous resolution of pituitary adenoma after apoplexy. J Neuroophthalmol 2000; 20: 42-44.
28. Wichers M, Kristof RA, Springer W, Schramm J, Klingmuller D. Pituitary apoplexy with spontaneous cure of acromegaly and its possible relation to GdDTPA-administration. Acta Neurochir (Wien) 1997; 139: 992-994.
29. Muller-Jensen A, Ludecke D. Clinical aspects of spontaneous necrosis of pituitary tumors (pituitary apoplexy. J Neurol 1981; 224: 267-271.
30. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 1999; 51: 181-188.